Full text is available at the source.
Abstract
Physical activity patterns among U.S. adults taking a glucagon-like peptide 1 receptor agonist (GLP-1RA) are not well understood.
- The effectiveness of GLP-1RAs for obesity and diabetes management is established.
- There is limited information on how these medications influence physical activity levels.
- The study aims to identify factors linked to low physical activity in this population.
- Sociodemographic and clinical factors may correlate with variations in activity levels.
Simplified